SC
EBACU

Sculptor Capital’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Sculptor Capital’s Portfolio EBACU Stock Details EBACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed – – 995
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1254
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1328
2022
Q1 		$0 Hold
2
– – ﹤0.01% 1446
2021
Q4 		$0 Hold
2
– – ﹤0.01% 1274
2021
Q3 		$0 Hold
2
– – ﹤0.01% 1092
2021
Q2 		$0 Sell
2
-199,998
-100% -$2M ﹤0.01% 1044
2021
Q1 		$2.01M Buy
+200,000
New +$2M 0.02% 430

Other funds holding EBACU

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Sculptor Capital's EBACU Position: Q4 2022 in Review

Sculptor Capital sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2022, closing a stake of 2 shares.

Sculptor Capital first reported a position in EBACU in Q1 2021 and held it in 7 quarters. The position peaked at $2.01M in Q1 2021. 11 funds tracked by Wall St. Rank hold EBACU as of Q4 2022.

  • Sculptor Capital reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
  • Sculptor Capital sold 2 European Biotech Acquisition Corp. Units shares in Q4 2022.
  • Sculptor Capital first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 7 quarters.
  • Sculptor Capital's European Biotech Acquisition Corp. Units position peaked at $2.01M in Q1 2021.
  • 11 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2022.

Based on Sculptor Capital's 13F filing for Q4 2022, filed 14 Feb 2023.